Showing results (31-40 of 2,045) with videos related to
Sort By:
Pageof 205
Journal of Neural Transmission (Vienna, Austria : 1996)|December 18, 2002
Moderate hyperhomocysteinaemia and immune activation in Parkinson's diseaseB Widner, F Leblhuber, B Frick, et al.The Journal of Infectious Diseases|June 6, 2000
Central nervous system activation of the indoleamine-2,3-dioxygenase pathway in human T cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesisE M Maloney, O St Claire Morgan, B Widner, et al.Advances in Experimental Medicine and Biology|March 18, 2000
Fructose malabsorption is associated with decreased plasma tryptophanM Ledochowski, B Widner, T Propst-Braunsteiner, et al.Anticancer Research|September 2, 1999
Increased neopterin concentrations in patients with cancer: indicator of oxidative stress?C Murr, L C Fuith, B Widner, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|July 19, 2001
Hyperhomocysteinemia in dementiaF Leblhuber, J Walli, E Artner-Dworzak, et al.British Journal of Cancer|June 28, 2002
Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancerA Huang, D Fuchs, B Widner, et al.Clinical Chemistry and Laboratory Medicine|December 16, 1998
Activated immune system in patients with Huntington's diseaseF Leblhuber, J Walli, K Jellinger, et al.Critical Reviews in Clinical Laboratory Sciences|January 1, 1992
The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseasesD Fuchs, G Weiss, G Reibnegger, et al.International Archives of Allergy and Immunology|November 18, 1997
Streptococcal erythrogenic toxins induce tryptophan degradation in human peripheral blood mononuclear cellsC Murr, B Widner, D Gerlach, et al.Current Drug Metabolism|April 14, 2007
Chronic immune activation underlies morbid obesity: is IDO a key player?G Brandacher, E Hoeller, D Fuchs, et al.Pageof 205